Head-to-head dispatch
Ark Health vs NowPatient
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Ark Health is a national direct-to-consumer telehealth platform with one of the widest menus in the directory — compounded semaglutide ($169/mo), tirzepatide ($249/mo) and oral semaglutide ($125/mo), plus…
Marked down on: States served not listed — can't confirm coverage in your state without contacting support
Desk Score
NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.
Marked down on: Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
Ark Health takes this head-to-head with the higher Desk Score, 65/100 (C) against 59/100 (C) for NowPatient. NowPatient still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Ark Health
65/100
C
NowPatient
59/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Ark Health | NowPatient |
|---|---|---|
| Semaglutide | $1,399/mo (brand Ozempic) | $1,349/mo (brand Wegovy) |
| Tirzepatide | $1,499/mo (brand Mounjaro) | $1,069/mo (brand Mounjaro, promotional rate) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name | Yes | Yes |
| Oral option | Yes | Yes |
| Best for | Readers who want broadest single-platform menu — compounded, brand and wellness adjuncts. | Readers who want brand-name GLP-1 access without a compounded route. |
| Desk Score | 65/100C | 59/100C |
The verdict
Desk pick — Ark HealthArk Health takes this head-to-head with the higher Desk Score, 65/100 (C) against 59/100 (C) for NowPatient. NowPatient still holds its ground where its strengths line up with yours.
Choose Ark Health if…
Readers who want broadest single-platform menu — compounded, brand and wellness adjuncts.
$1,399/mo (brand Ozempic) sema · $1,499/mo (brand Mounjaro) tirz · Coverage not published
Choose NowPatient if…
Readers who want brand-name GLP-1 access without a compounded route.
$1,349/mo (brand Wegovy) sema · $1,069/mo (brand Mounjaro, promotional rate) tirz · Coverage not published
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way. Read full breakdowns: Ark Health · NowPatient.
Also here
CoreAge Rx tops every dispatch at 94/100
Whichever of these two you lean toward, the Desk's #1-rated provider outscores them both. The Desk's top dispatch: flat all-in pricing, both molecules, all 50 states — no teaser-rate traps.
More head-to-heads
- Ark Health vs CoreAge Rx
- NowPatient vs Vaylen
- Ark Health vs Strut Health
- NowPatient vs Ondra Health
- Ark Health vs Invigor Medical
- NowPatient vs Vytora Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.